Literature DB >> 4102485

Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis.

B Weeke, S Jarnum.   

Abstract

The serum concentration of 19 serum proteins was determined by electrophoresis in 42 patients with Crohn's disease and 36 patients with ulcerative colitis. The results were compared with 78 healthy persons as matched controls. Distinctive, but similar, changes were present in the two diseases. An increased serum concentration of orosomucoid, alpha(1)-antitrypsin, easily precipitable glycoprotein, alpha(1)-antichymotrypsin, haptoglobin, and haemopexin was present. The serum concentration was decreased for prealbumin, albumin, alpha(2)-HS glycoprotein, caeruloplasmin, alpha(2)-macro-globulin, and transferrin. No significant difference between the two diseases existed as far as the serum protein pattern was concerned. Certain proteins, ;the acute phase reactants' (orosomucoid, alpha(1)-antitrypsin, alpha(1)-antichymotrypsin, and haptoglobin) and the immunoglobulins were clinically useful, since their serum concentration reflected the grade of activity of the disease. A pronounced elevation of haptoglobin compared with that of the other ;acute phase reactants' was present in patients with Crohn's disease complicated by suppurative fistulas or abscesses. Patients with active Crohn's disease who responded favourably to medical treatment had significantly higher immunoglobulin levels than patients not responding. A similar observation, though not statistically significant, was made in patients with ulcerative colitis.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4102485      PMCID: PMC1411620          DOI: 10.1136/gut.12.4.297

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  15 in total

1.  The serum proteins identified by means of the Laurell crossed electrophoresis.

Authors:  B Weeke
Journal:  Scand J Clin Lab Invest       Date:  1970-05       Impact factor: 1.713

2.  IgG and albumin turnover in Crohn's disease.

Authors:  G Bendixen; S Jarnum; J Soltoft; H Westergaard; B Weeke; M Yssing
Journal:  Scand J Gastroenterol       Date:  1968       Impact factor: 2.423

3.  Quantitative estimation of human immunoglobulins following carbamylation by electrophoresis in antibody-containing agarose.

Authors:  B Weeke
Journal:  Scand J Clin Lab Invest       Date:  1968       Impact factor: 1.713

4.  Prognostic value of the serum proteins during severe attacks of ulcerative colitis.

Authors:  F T De Dombal
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

5.  Serum immunoglobulins and organ-specific, cellular hypersensitivity in ulcerative colitis and Crohn's disease.

Authors:  B Weeke; G Bendixen
Journal:  Acta Med Scand       Date:  1969 Jul-Aug

6.  Prognostic value of estimating serum proteins in cases of ulcerative colitis in remission.

Authors:  F T De Dombal
Journal:  Gut       Date:  1969-06       Impact factor: 23.059

7.  [Immunochemical determination of serum albumin, transferrin, IgG, IgA and IgM].

Authors:  B Weeke
Journal:  Ugeskr Laeger       Date:  1969-08-21

8.  IgM turnover in Crohn's disease.

Authors:  K B Jensen; N Goltermann; S Jarnum; B Weeke; H Westergaard
Journal:  Gut       Date:  1970-03       Impact factor: 23.059

9.  Immunoglobulin and albumin turnover in ulcerative colitis.

Authors:  G Bendixen; N Goltermann; S Jarnum; K B Jensen; B Weeke; H Westergaard
Journal:  Scand J Gastroenterol       Date:  1970       Impact factor: 2.423

10.  Serum alpha 1-acid glycoprotein in chronic ulcerative colitis.

Authors:  W H Dearing; W F McGuckin; L R Elveback
Journal:  Gastroenterology       Date:  1969-02       Impact factor: 22.682

View more
  28 in total

1.  Comparative mapping of the local distribution of immunoglobulin-containing cells in ulcerative colitis and Crohn's disease of the colon.

Authors:  K Baklien; P Brandtzaeg
Journal:  Clin Exp Immunol       Date:  1975-11       Impact factor: 4.330

2.  Synthesis of plasma haemopexin, albumin and fibrinogen by the regenerating rat liver.

Authors:  I M Murray-Lyon; H H Liem; U Muller-Eberhard
Journal:  Br J Exp Pathol       Date:  1975-06

3.  Novel serum protein biomarkers indicative of growth hormone doping in healthy human subjects.

Authors:  Juan Ding; Shigeru Okada; Jens Otto Lunde Jørgensen; John J Kopchick
Journal:  Proteomics       Date:  2011-07-27       Impact factor: 3.984

4.  Protein synthesis rates in colon and liver: stimulation by gastrointestinal pathologies.

Authors:  S D Heys; K G Park; M A McNurlan; R A Keenan; J D Miller; O Eremin; P J Garlick
Journal:  Gut       Date:  1992-07       Impact factor: 23.059

5.  The immune response to phi chi 174 in man. II. Primary and secondary antibody production in patients with Crohn's disease.

Authors:  R C Bucknall; J V Jones; D B Peacock
Journal:  Am J Dig Dis       Date:  1975-05

6.  Selective IgA deficiency and Crohn's disease: report of two cases.

Authors:  H J Hodgson; D P Jewell
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

7.  Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies.

Authors:  Jessica Wojciechowski; Richard N Upton; Diane R Mould; Michael D Wiese; David J R Foster
Journal:  AAPS J       Date:  2017-04-25       Impact factor: 4.009

8.  Comments on "Serum Urea:Albumin Ratio as a Prognostic Marker in Critical Patients With Non-chronic Kidney Disease".

Authors:  Kirtimaan Syal
Journal:  Indian J Clin Biochem       Date:  2014-04-26

9.  The humoral immune system in inflammatory bowel disease. II. Immunologlobulin levels.

Authors:  H J Hodgson; D P Jewell
Journal:  Am J Dig Dis       Date:  1978-02

10.  Is tube feeding with elemental diets a primary therapy of Crohn's disease?

Authors:  H Lochs; M Egger-Schödl; R Schuh; S Meryn; G Westphal; R Pötzi
Journal:  Klin Wochenschr       Date:  1984-09-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.